These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

142 related items for PubMed ID: 17925606

  • 21. Clinical utility of C-reactive protein measured at admission, hospital discharge, and 1 month later to predict outcome in patients with acute coronary disease. The RISCA (recurrence and inflammation in the acute coronary syndromes) study.
    Bogaty P, Boyer L, Simard S, Dauwe F, Dupuis R, Verret B, Huynh T, Bertrand F, Dagenais GR, Brophy JM.
    J Am Coll Cardiol; 2008 Jun 17; 51(24):2339-46. PubMed ID: 18549920
    [Abstract] [Full Text] [Related]

  • 22. Increased circulating C-reactive protein and macrophage-colony stimulating factor are complementary predictors of long-term outcome in patients with chronic coronary artery disease.
    Ikonomidis I, Lekakis J, Revela I, Andreotti F, Nihoyannopoulos P.
    Eur Heart J; 2005 Aug 17; 26(16):1618-24. PubMed ID: 15800017
    [Abstract] [Full Text] [Related]

  • 23. C-reactive protein 1059G/C gene polymorphism, C-reactive protein levels and acute myocardial infarction.
    Ghattas MH, Abo-Elmatty DM, El-Eraki AZ.
    J Cardiovasc Med (Hagerstown); 2012 Nov 17; 13(11):716-9. PubMed ID: 22828776
    [Abstract] [Full Text] [Related]

  • 24. Role of the CD14 C(-260)T promoter polymorphism in determining the first clinical manifestation of coronary artery disease.
    Rizzello V, Liuzzo G, Trabetti E, Di Giannuario G, Brugaletta S, Santamaria M, Piro M, Boccanelli A, Pignatti PF, Biasucci LM, Crea F.
    J Cardiovasc Med (Hagerstown); 2010 Jan 17; 11(1):20-5. PubMed ID: 19829130
    [Abstract] [Full Text] [Related]

  • 25. Usefulness of combining complement factor H and C-reactive protein genetic profiles for predicting myocardial infarction (from the Rotterdam Study).
    Kardys I, de Maat MP, Klaver CC, Despriet DD, Uitterlinden AG, Hofman A, de Jong PT, Witteman JC.
    Am J Cardiol; 2007 Aug 15; 100(4):646-8. PubMed ID: 17697822
    [Abstract] [Full Text] [Related]

  • 26. Comorbidity and acute clinical events as determinants of C-reactive protein variation in hemodialysis patients: implications for patient survival.
    Snaedal S, Heimbürger O, Qureshi AR, Danielsson A, Wikström B, Fellström B, Fehrman-Ekholm I, Carrero JJ, Alvestrand A, Stenvinkel P, Bárány P.
    Am J Kidney Dis; 2009 Jun 15; 53(6):1024-33. PubMed ID: 19394732
    [Abstract] [Full Text] [Related]

  • 27. Plasma levels of fibrinogen and C-reactive protein are related to interleukin-6 gene -572C>G polymorphism in subjects with and without hypertension.
    Wong LY, Leung RY, Ong KL, Cheung BM.
    J Hum Hypertens; 2007 Nov 15; 21(11):875-82. PubMed ID: 17508011
    [Abstract] [Full Text] [Related]

  • 28. Instability mechanisms in unstable angina according to baseline serum levels of C-reactive protein: the role of thrombosis, fibrinolysis and atherosclerotic burden.
    Niccoli G, Biasucci LM, Biscione C, Buffon A, Siviglia M, Conte M, Porto I, Graziani F, Liuzzo G, Crea F.
    Int J Cardiol; 2007 Nov 30; 122(3):245-7. PubMed ID: 17270293
    [Abstract] [Full Text] [Related]

  • 29. Ceruloplasmin is a better predictor of the long-term prognosis compared with fibrinogen, CRP, and IL-6 in patients with severe unstable angina.
    Ziakas A, Gavrilidis S, Souliou E, Giannoglou G, Stiliadis I, Karvounis H, Efthimiadis G, Mochlas S, Vayona MA, Hatzitolios A, Savopoulos C, Pidonia I, Parharidis G.
    Angiology; 2009 Nov 30; 60(1):50-9. PubMed ID: 18388036
    [Abstract] [Full Text] [Related]

  • 30. Reduction of C-reactive protein by a single 80 mg of simvastatin in patients with unstable angina.
    Li JJ, Wang Y, Nie SP, Zhang CY, Li YS, Hui RT, Zhen X.
    Clin Chim Acta; 2007 Feb 30; 376(1-2):163-7. PubMed ID: 16999946
    [Abstract] [Full Text] [Related]

  • 31. Preprocedural high-sensitivity C-reactive protein predicts death or myocardial infarction but not target vessel revascularization or stent thrombosis after percutaneous coronary intervention.
    Delhaye C, Sudre A, Lemesle G, Maréchaux S, Broucqsault D, Hennache B, Bauters C, Lablanche JM.
    Cardiovasc Revasc Med; 2009 Feb 30; 10(3):144-50. PubMed ID: 19595394
    [Abstract] [Full Text] [Related]

  • 32. Increased peripheral circulating inflammatory cells and plasma inflammatory markers in patients with variant angina.
    Li JJ, Zhang YP, Yang P, Zeng HS, Qian XW, Zhang CY, Zhu CG, Li J, Nan JL.
    Coron Artery Dis; 2008 Aug 30; 19(5):293-7. PubMed ID: 18607165
    [Abstract] [Full Text] [Related]

  • 33. Association of C-reactive protein with blood pressure and hypertension: life course confounding and mendelian randomization tests of causality.
    Davey Smith G, Lawlor DA, Harbord R, Timpson N, Rumley A, Lowe GD, Day IN, Ebrahim S.
    Arterioscler Thromb Vasc Biol; 2005 May 30; 25(5):1051-6. PubMed ID: 15731495
    [Abstract] [Full Text] [Related]

  • 34. Association of the -757T>C polymorphism in the CRP gene with circulating C-reactive protein levels and carotid atherosclerosis.
    Ben Assayag E, Shenhar-Tsarfaty S, Bova I, Berliner S, Usher S, Peretz H, Shapira I, Bornstein NM.
    Thromb Res; 2009 Sep 30; 124(4):458-62. PubMed ID: 19428053
    [Abstract] [Full Text] [Related]

  • 35. [Markers of inflammation--monocyte chemoattractant protein-1 (MCP-1) and C-reactive protein--in blood of patients with unstable angina pectoris and stable effort angina].
    Provatoriv SI, Aref'eva TI, Kukhtina NB, Liukova TK, Aref'eva AM, Krasnikova TL.
    Ter Arkh; 2006 Sep 30; 78(6):66-9. PubMed ID: 16881366
    [Abstract] [Full Text] [Related]

  • 36. Usefulness of combining serum uric acid and C-reactive protein for risk stratification of patients with coronary artery disease (Bezafibrate Infarction Prevention [BIP] study).
    Brodov Y, Behar S, Goldenberg I, Boyko V, Chouraqui P.
    Am J Cardiol; 2009 Jul 15; 104(2):194-8. PubMed ID: 19576345
    [Abstract] [Full Text] [Related]

  • 37. Allelic variation at the C-reactive protein gene associates to both hand osteoarthritis severity and serum high sensitive C-reactive protein levels in the GARP study.
    Bos SD, Suchiman HE, Kloppenburg M, Houwing-Duistermaat JJ, le Graverand MP, Seymour AB, Kroon HM, Slagboom PE, Meulenbelt I.
    Ann Rheum Dis; 2008 Jun 15; 67(6):877-9. PubMed ID: 18055473
    [Abstract] [Full Text] [Related]

  • 38. [Prognostic value of high-sensitivity C-reactive protein in assessing intrahospital outcome of unstable angina].
    Ben Halima A, Kammoun I, Sdiri W, Bachraoui K, Chine S, Zoaoui W, Châabène O, Gargouri S, Keskes H, Lefi A, Ben Ammar S, Boujnah MR, Kachboura S.
    Tunis Med; 2003 Jun 15; 81 Suppl 8():632-7. PubMed ID: 14608751
    [Abstract] [Full Text] [Related]

  • 39. The value of N-terminal fragment of brain natriuretic peptide and tissue inhibitor of metalloproteinase-1 levels as predictors of cardiovascular outcome in the LIPID study.
    West MJ, Nestel PJ, Kirby AC, Schnabel R, Sullivan D, Simes RJ, Pollicino C, Lubos E, Münzel TF, White HD, Tonkin AM, Bickel C, Tiret L, Blankenberg S, LIPID Study Investigators.
    Eur Heart J; 2008 Apr 15; 29(7):923-31. PubMed ID: 18296678
    [Abstract] [Full Text] [Related]

  • 40. C-reactive protein, bezafibrate, and recurrent coronary events in patients with chronic coronary heart disease.
    Haim M, Benderly M, Tanne D, Matas Z, Boyko V, Fisman EZ, Tenenbaum A, Zimmlichman R, Battler A, Goldbourt U, Behar S.
    Am Heart J; 2007 Dec 15; 154(6):1095-101. PubMed ID: 18035081
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.